Bariatric: Codes noted include 43644, 43645. Prior authorization effective date: Jan. 1, 2015.
Bone Growth Stimulator: Codes include 20975, 20979 (also listed with 20974 in some entries). Prior authorization effective dates include Jan. 1, 2014; Jan. 1, 2015; Oct. 1, 2022; and Apr. 1, 2026 depending on code/plan.
Breast Reconstruction: Codes include 11971 and non-mastectomy reconstruction codes 19316, 19318, 19325. Prior authorization effective date: Oct. 1, 2022 for some codes; prior authorization not required for specified codes with qualifying DX codes (see full table).
Cancer Supportive Care (Colony-Stimulating Factors, Erythropoiesis-Stimulating Agents, Antiemetic Drugs, Bone-Modifying Agents, other oncology injectables): Multiple HCPCS/J-codes listed across entries (examples: Q5136, Q5158, J1449, J1456, J1448, J0897, Q5120, Q5108, Q5111, J2820, Q5160, J9073, J9075, J9249, J9184, J9326, J9011, J9282). Prior authorization effective dates vary (examples: Apr. 1, 2026; Oct. 1, 2023; July 1, 2023; Jan. 1, 2022; July 1, 2020; Feb. 1, 2021; July 1, 2024; Jan. 1, 2023). Many entries require prior authorization when billed with oncology diagnosis codes; some require authorization regardless of diagnosis for specific drugs. Submit oncology drug requests via the Provider Portal or call the listed prior authorization line where indicated.
Cardiology: Select CPT codes and procedures (examples noted: 33274, 33270, 33221, 33225, 33228, and angiography/diagnostic codes 93351, 93453, 93455, 93457). For certain cardiac procedures (example: 93580) prior authorization required for members age 18 and older. Prior authorization effective dates include Apr. 1, 2026 and April 1, 2022 for specific items. For details and full CPT lists visit UHCprovider.com/TXcommunityplan > Prior Authorization and Notification Resources > Cardiology Prior Authorization.
Inpatient monitoring / chemotherapy: Inpatient video EEG and inpatient chemotherapy codes listed (examples: 95726, 95720, 95724, J9011, J9282) — prior authorization is required for inpatient services. Prior authorization effective dates include Mar. 1, 2020; Jan. 1, 2020; Apr. 1, 2026. Prior authorization is not required for outpatient hospital or ambulatory surgical center services for some monitoring codes.
Outpatient chemotherapy / injectable oncology: Injectable chemotherapy and supportive oncology drugs administered in outpatient settings are listed (examples: 95718, 95722, J9184, J9326, multiple J-codes). Prior authorization effective dates vary; some agents require authorization for oncology diagnoses only, others require authorization regardless of diagnosis. Submit requests via the Provider Portal; telephone numbers provided in the full table for certain codes.
Additional oncology groups: Multiple entries list specific J-codes that require prior authorization regardless of cancer diagnosis (examples include J9056, J9059, J9259, J9323, J9350, J9294, J9297, J9048, J9314, J9394, J9298, J9332) with various effective dates (Oct. 1, 2023; July 1, 2023; May 1, 2023; Jan. 1, 2023). For some drugs (e.g., J9331, J9071, J9331 alone) prior authorization effective date Jan. 1, 2023 is noted.
Recurrent / repeated listings: The source contains repeated and fragmented entries for many of the same service groups and codes (bone growth stimulators, oncology injectables, etc.) with differing effective dates and notes; authoritative rules depend on code, date, and diagnosis gating found in the master PA table.